Kenosha 25-acre Development Project
Location: Kenosha, Wisconsin, United States
Source: The Business Journals
A $45 million development project on a 25-acre site in Kenosha, which the developer has walked away from, indicating a failure or delay in the project.
Project Information FAQ
Project Information
Want to explore the full details? View the full report
Participants
Sponsoring Agency | Obfuscated Data |
Company | Obfuscated Data |
Status
Original status | cancelled |
Taiyo status | Obfuscated Data |
Taiyo last update | 00-00-0000 |
Available timestamps | 00-00-0000 |
Available timestamp type | Obfuscated Data |
Contact
Contact name | Obfuscated Data |
Phone | 0000000000 |
ObfuscatedData@email.com | |
Address | Obfuscated Data, Obfuscated data, obfuscated data, Obfuscated data |
Description
Description | A $45 million development project on a 25-acre site in Kenosha, which the developer has walked away from, indicating a failure or delay in the project. |
Original sub-sector | Obfuscated |
Original Currency | USD |
Original budget | 000000000000000 |
Procurement method | Obfuscated Data |
Budget | 000000000000000 |
Location
Region | Obfuscated |
Country | Obfuscated |
State | Obfuscated Data |
County | Obfuscated |
Location | Obfuscated Data, Obfuscated data, obfuscated data, Obfuscated data |
Source
Source reliability | High |
Data quality score | 100% |
Source | Obfuscated Data |
URL | obfuscated_data,obfuscateddata.com |
More Details
Project Type | Obfuscated Data |
Article Published Date | Obfuscated Data |
More infrastructure projects in United States
- EPC of Turbine and Foundation Structure in the Southwest Sea Wind Power Demonstration Complex
- Engineering, Procurement, and Construction of Third Bosphorus Bridge
- Morphotek’s New Biologics Production Facility
- Romark’s New Manufacturing Facility, Manati
- LabCentral 238, Cambridge, Massachusetts, USA
- Medical and Research Translation (MART) Building, Stony Brook University
- Abzena’s Biotherapeutics Manufacturing Facility Relocation, San Diego
- Kite Pharma’s Viral Vector Manufacturing Facility, California, US